Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AXSM

Axsome Therapeutics

$10.15

0.16 (1.60%)

07:19
02/06/19
02/06
07:19
02/06/19
07:19
Hot Stocks
Axsome Therapeutics reaches agreement under SPA for MOMENTUM Phase 3 trial »

Axsome Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$9.14

0.78 (9.33%)

13:45
02/01/19
02/01
13:45
02/01/19
13:45
Options
Axsome Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$8.12

-0.05 (-0.61%)

07:17
01/30/19
01/30
07:17
01/30/19
07:17
Hot Stocks
Axsome Therapeutics initiates CONCERT study »

Axsome Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
AXSM

Axsome Therapeutics

$6.87

(0.00%)

09:43
01/08/19
01/08
09:43
01/08/19
09:43
Recommendations
Axsome Therapeutics analyst commentary at BTIG »

Axsome Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

AXSM

Axsome Therapeutics

$6.56

3.92 (148.48%)

11:05
01/07/19
01/07
11:05
01/07/19
11:05
Recommendations
Axsome Therapeutics analyst commentary at Ladenburg »

Axsome Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

AXSM

Axsome Therapeutics

$6.58

3.94 (149.24%)

10:59
01/07/19
01/07
10:59
01/07/19
10:59
Recommendations
Axsome Therapeutics analyst commentary at Ladenburg »

Axsome Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

LOXO

Loxo Oncology

$139.82

8.92 (6.81%)

, LLY

Eli Lilly

$114.65

3.36 (3.02%)

09:12
01/07/19
01/07
09:12
01/07/19
09:12
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Loxo Oncology…

LOXO

Loxo Oncology

$139.82

8.92 (6.81%)

LLY

Eli Lilly

$114.65

3.36 (3.02%)

SAGE

Sage Therapeutics

$97.44

7.93 (8.86%)

EPZM

Epizyme

$7.93

1.94 (32.39%)

AXSM

Axsome Therapeutics

$2.64

-0.01 (-0.38%)

EXAS

Exact Sciences

$65.63

3.63 (5.85%)

CMC

Commercial Metals

$17.08

1.09 (6.82%)

HCLP

Hi-Crush Partners

$4.35

0.33 (8.21%)

BTI

British American Tobacco

$32.99

1.39 (4.40%)

PCG

PG&E

$24.40

0.455 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 08

    Jan

  • 09

    Jan

  • 14

    Jan

  • 15

    Jan

  • 16

    Jan

  • 28

    Jan

  • 10

    Feb

  • 19

    Mar

  • 18

    May

AXSM

Axsome Therapeutics

$2.64

-0.01 (-0.38%)

08:25
01/07/19
01/07
08:25
01/07/19
08:25
Conference/Events
Axsome Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

AXSM

Axsome Therapeutics

$2.64

-0.01 (-0.38%)

07:42
01/07/19
01/07
07:42
01/07/19
07:42
Recommendations
Axsome Therapeutics analyst commentary at H.C. Wainwright »

Axsome Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

AXSM

Axsome Therapeutics

$2.64

-0.01 (-0.38%)

06:36
01/07/19
01/07
06:36
01/07/19
06:36
Conference/Events
Axsome Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.